In the context of allergic asthma, programmed death ligand B7DC (PD-L2) has been shown to be upregulated after allergen sensitization in murine myeloid DCs which correlates with the severity of the disease in humans. This evidence concerns the gene PDCD1LG2 and allergic asthma.